Demonstrates neuroprotective effects against excitotoxicity in models of Alzheimer's disease, indicating potential benefits in early-stage treatment.
exerts neuroprotective effects against glutamate-induced excitotoxicity in primary hippocampal neurons while additionally modulating glutamatergic homeostasis and redox balance through functional mechanisms in astrocyte-based models, supporting its relevance as a multitarget preclinical candidate for early stage AD mechanisms.
No takes yet. Share an insight, caveat, or question.
Hacımüftüoğlu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: